BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Han W, Shi CT, Cao FY, Cao F, Chen MB, Lu RZ, Wang HB, Yu M, He DW, Wang QH, Wang JF, Xu XX, Ding HZ. Prognostic Value of NME1 (NM23-H1) in Patients with Digestive System Neoplasms: A Systematic Review and Meta-Analysis. PLoS One 2016;11:e0160547. [PMID: 27518571 DOI: 10.1371/journal.pone.0160547] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Marioni G, Cappellesso R, Ottaviano G, Fasanaro E, Marchese-ragona R, Favaretto N, Giacomelli L, Guzzardo V, Martini A, Fassina A, Blandamura S. Nuclear nonmetastatic protein 23-H1 expression and epithelial-mesenchymal transition in laryngeal carcinoma: A pilot investigation. Head & Neck 2018;40:2020-8. [DOI: 10.1002/hed.25188] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
2 Fiorino S, Bacchi-reggiani ML, Birtolo C, Acquaviva G, Visani M, Fornelli A, Masetti M, Tura A, Sbrignadello S, Grizzi F, Patrinicola F, Zanello M, Mastrangelo L, Lombardi R, Benini C, Di Tommaso L, Bondi A, Monetti F, Siopis E, Orlandi PE, Imbriani M, Fabbri C, Giovanelli S, Domanico A, Accogli E, Di Saverio S, Grifoni D, Cennamo V, Leandri P, Jovine E, de Biase D. Matricellular proteins and survival in patients with pancreatic cancer: A systematic review. Pancreatology 2018;18:122-32. [DOI: 10.1016/j.pan.2017.11.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
3 Zheng S, Liu T, Liu Q, Yang L, Zhang Q, Han X, Shen T, Zhang X, Lu X. Widely targeted metabolomic analyses unveil the metabolic variations after stable knock-down of NME4 in esophageal squamous cell carcinoma cells. Mol Cell Biochem 2020;471:81-9. [PMID: 32504364 DOI: 10.1007/s11010-020-03768-w] [Reference Citation Analysis]
4 Camacho D, Jesus JP, Palma AM, Martins SA, Afonso A, Peixoto ML, Pelham CJ, Moreno E, Gogna R. SPARC-p53: The double agents of cancer. Adv Cancer Res 2020;148:171-99. [PMID: 32723563 DOI: 10.1016/bs.acr.2020.05.004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
5 Gao G, Yu Z, Zhao X, Fu X, Liu S, Liang S, Deng A. Immune classification and identification of prognostic genes for uveal melanoma based on six immune cell signatures. Sci Rep 2021;11:22244. [PMID: 34782661 DOI: 10.1038/s41598-021-01627-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Mingina T, Zhao M. Role of PARK7 and NDKA in stroke management: a review of PARK7 and NDKA as stroke biomarkers. Biomark Med 2018;12:419-25. [PMID: 29697269 DOI: 10.2217/bmm-2018-0013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Xiao Y, Zhang H, Ma Q, Huang R, Lu J, Liang X, Liu X, Zhang Z, Yu L, Pang J, Zhou L, Liu T, Wu H, Liang Z. YAP1-mediated pancreatic stellate cell activation inhibits pancreatic cancer cell proliferation. Cancer Lett 2019;462:51-60. [PMID: 31352078 DOI: 10.1016/j.canlet.2019.07.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
8 Wang J, Miao Y, Ran J, Yang Y, Guan Q, Mi D. Construction prognosis model based on autophagy-related gene signatures in hepatocellular carcinoma. Biomark Med 2020;14:1229-42. [PMID: 33021390 DOI: 10.2217/bmm-2020-0170] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Lapitz A, Arbelaiz A, O'Rourke CJ, Lavin JL, Casta A, Ibarra C, Jimeno JP, Santos-Laso A, Izquierdo-Sanchez L, Krawczyk M, Perugorria MJ, Jimenez-Aguero R, Sanchez-Campos A, Riaño I, Gónzalez E, Lammert F, Marzioni M, Macias RIR, Marin JJG, Karlsen TH, Bujanda L, Falcón-Pérez JM, Andersen JB, Aransay AM, Rodrigues PM, Banales JM. Patients with Cholangiocarcinoma Present Specific RNA Profiles in Serum and Urine Extracellular Vesicles Mirroring the Tumor Expression: Novel Liquid Biopsy Biomarkers for Disease Diagnosis. Cells 2020;9:E721. [PMID: 32183400 DOI: 10.3390/cells9030721] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
10 Zhou C, Zhong X, Song Y, Shi J, Wu Z, Guo Z, Sun J, Wang Z. Prognostic Biomarkers for Gastric Cancer: An Umbrella Review of the Evidence. Front Oncol 2019;9:1321. [PMID: 31850212 DOI: 10.3389/fonc.2019.01321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]